
|Articles|August 13, 2015
GSK: Legionnaires Disease Bacteria Causes Temporary Closedown of US Site
August 13, 2015.
Advertisement
The
GSK said the bacteria had been isolated after routine testing and that it is “working to rectify and restore operations as soon as possible”.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
2
The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma
3
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5